SIRT-2 inhibitors (Guizhou Medical University/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences)

N/A

Report date: 2025/03/20 09:22:55
NME

Base Information

Drug NameSIRT-2 inhibitors (Guizhou Medical University/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-2 inhibitors
TargetsNAD-dependent protein deacetylase sirtuin-2
Therapy Area/IndicationsInflammationDiabetes MellitusParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuizhou Medical University
China Registration ClassN/A

Develop Information

Active CompaniesGuizhou Medical UniversityShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsInflammationDiabetes MellitusParkinson Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A